Home › SEC Filings
SEC Filing Analysis
All Current Report (8-K)Annual Report (10-K)Quarterly Report (10-Q)Form 4 Insider TradesSC 13D Beneficial Ownership13F Institutional HoldingsPress ReleasesInsider Cluster ActivityInsider Buy Activity
Theme?
All themes Artificial IntelligenceSemiconductorsQuantum ComputingSpace & SatellitesRobotics & AutomationElectric VehiclesClean & Renewable EnergyBattery & Energy StorageNuclear & FusionCybersecurityCloud & SaaSFintech & PaymentsCrypto & BlockchainGenomics & Gene EditingBiotech & Drug DiscoveryE-commerce & PlatformsStreaming & Digital MediaGaming & EsportsDefense TechCannabis
| Ticker | Type | Sentiment | Impact | Summary | Date |
|---|---|---|---|---|---|
| SLNO | INST-CLUSTER | mixed | 4/10 | Six institutional investors accumulated $883.9M in SLNO (net +$345.5M) while four reduced holdings by -$139.4M. The buyi | Jun 11, 2026 |
| KALV | INST-CLUSTER | neutral | 2/10 | An institutional cluster for KalVista Pharmaceuticals shows 4 passive buyers (Wells Fargo, Schwab, Morgan Stanley, UBS) | Jun 11, 2026 |
| DNTH | INST-CLUSTER | bullish | 5/10 | Five institutional investors (including two hedge funds with strong alpha track records, Citadel and Point72) added $233 | Jun 11, 2026 |
| SRRK | INST-CLUSTER | bearish | 6/10 | A bearish institutional cluster formed in SRRK during Q3 2025, with 6 sellers (including Norges Bank, Citadel, and RenTe | Jun 11, 2026 |
| CMPS | INST-CLUSTER | bullish | 5/10 | Six major institutional investors, including Morgan Stanley, UBS, Two Sigma, and RenTech, significantly increased their | Jun 11, 2026 |
| PRAX | INST-CLUSTER | mixed | 4/10 | Three institutional investors added $58.3M to PRAX positions in Q3 2025, led by Point72's $39.2M increase, while two sel | Jun 11, 2026 |
| JANX | INST-CLUSTER | neutral | 2/10 | Institutional cluster for JANX shows mixed Q3 activity: four passive buyers (State Street, Invesco, UBS, Morgan Stanley) | Jun 11, 2026 |
| NRSN | 6-K | neutral | 4/10 | NeuroSense Therapeutics announced it was granted a South Korean patent covering its lead ALS drug PrimeC, providing prot | Jun 11, 2026 |
| JAGX | 8-K | bearish | 8/10 | Jaguar Health entered into two capital-raising agreements with C/M Capital Partners on June 9, 2026: (1) an equity line | Jun 11, 2026 |
| RARE | INST-CLUSTER | neutral | 4/10 | A mixed institutional cluster in Ultragenyx (RARE) for Q3 2025 shows $368.2M in aggregate buying by 5 institutions (led | Jun 11, 2026 |
| GMAB | INST-CLUSTER | bearish | 4/10 | An institutional cluster in GMAB shows mixed conviction: two passive funds (Fidelity, Schwab) added $21.8M in new holdin | Jun 11, 2026 |
| MREO | INST-CLUSTER | neutral | 4/10 | Institutional cluster shows net accumulation in MREO during 2025-Q3, with 4 buyers adding $10.4M and 1 seller reducing $ | Jun 11, 2026 |
| CGEM | INST-CLUSTER | neutral | 3/10 | Three institutional investors (Morgan Stanley, Invesco, RenTech) added to their CGEM positions in Q3 2025, while two (Fi | Jun 11, 2026 |
| CLDX | INST-CLUSTER | neutral | 4/10 | A mixed institutional cluster in CLDX for Q3 2025 shows two mega-passive buyers (Wells Fargo, Invesco) adding modest pos | Jun 11, 2026 |
| REPL | INST-CLUSTER | bearish | 4/10 | In Q3 2025, four mega-passive institutions (Fidelity, Morgan Stanley, Invesco, UBS) increased their REPL holdings by a n | Jun 11, 2026 |
| STTK | 8-K | bearish | 6/10 | Shattuck Labs closed a $75M underwritten public offering of 10.9M common shares and 7.9M pre-funded warrants at $4.00/sh | Jun 11, 2026 |
| DNLI | INST-CLUSTER | mixed | 4/10 | Mixed institutional activity in Denali Therapeutics for 2025-Q3: 3 large passive buyers (Morgan Stanley, UBS, BofA) adde | Jun 11, 2026 |
| GOSS | INST-CLUSTER | neutral | 3/10 | Four mega-passive institutional investors (State Street, Invesco, UBS, BofA) significantly increased their GOSS holdings | Jun 11, 2026 |
| MGNX | INST-CLUSTER | neutral | 3/10 | Four institutions increased their MGNX positions in Q3 2025 while one reduced, resulting in net buying of approximately | Jun 11, 2026 |
| ELVN | 8-K | bullish | 7/10 | Enliven Therapeutics reported updated positive Phase 1 data for ELVN-001 in CML, showing a 61% overall MMR and 48% MMR a | Jun 11, 2026 |
| KOD | INST-CLUSTER | bullish | 4/10 | Four mega-passive institutional investors (T. Rowe Price, Invesco, BofA, Morgan Stanley) aggressively accumulated Kodiak | Jun 11, 2026 |
| BAK | INST-CLUSTER | bearish | 5/10 | An institutional cluster for Braskem SA (BAK) in Q3 2025 shows mixed conviction: two passive funds added small positions | Jun 11, 2026 |
| CRBU | 8-K | bullish | 6/10 | Caribou Biosciences announced long-term follow-up data from its ANTLER phase 1 (vispa-cel, anti-CD19) and CaMMouflage ph | Jun 11, 2026 |
| LQDA | INST-CLUSTER | bullish | 5/10 | Six major passive asset managers increased their Liquidia Corp (LQDA) positions in Q3 2025, with aggregate holdings jump | Jun 11, 2026 |
| CRBU | PRESS-RELEASE | bullish | 7/10 | Caribou Biosciences reported longer follow-up data from the CaMMouflage Phase 1 trial of CB-011, an off-the-shelf BCMA-t | Jun 11, 2026 |
| TOVX | PRESS-RELEASE | bullish | 7/10 | Theriva Biologics announced publication of Phase 1 trial results for VCN-01 in immunotherapy-refractory HNSCC in Clinica | Jun 11, 2026 |
| RXRX | INST-CLUSTER | neutral | 3/10 | A cluster of five mega-passive institutions (State Street, Wells Fargo, Schwab, Invesco, Morgan Stanley) added $46.3M in | Jun 11, 2026 |
| VTYX | INST-CLUSTER | bearish | 4/10 | A bearish institutional cluster has formed in Ventyx Biosciences (VTYX) for Q3 2025, with 4 passive/universal-owner sell | Jun 11, 2026 |
| QDEL | INST-CLUSTER | neutral | 3/10 | Four mega-passive institutional investors (Fidelity, Invesco, BofA, UBS) collectively added $105.9M in QDEL during Q3 20 | Jun 11, 2026 |
| STTK | INST-CLUSTER | bearish | 4/10 | This 13F institutional cluster for Shattuck Labs (STTK) reveals one mega-passive buyer (Bank of America doubling a tiny | Jun 11, 2026 |